Descripción:

NSABP PROTOCOL B-36: FOLLOW-UP FORM Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer NCT00087178 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C89314D7-1DBA-74BA-E034-0003BA12F5E7

Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C89314D7-1DBA-74BA-E034-0003BA12F5E7
Palabras clave:
  1. 26/8/12 26/8/12 -
  2. 9/1/15 9/1/15 - Martin Dugas
  3. 13/4/15 13/4/15 - Martin Dugas
  4. 20/9/21 20/9/21 -
Subido en:

20 de septiembre de 2021

DOI:
Para solicitar uno, por favor iniciar sesión.
Licencia :
Creative Commons BY-NC 3.0 Legacy
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Breast Cancer FOLLOW-UP NSABP B-36 NCT00087178

No Instruction available.

  1. StudyEvent: NSABP PROTOCOL B-36: FOLLOW-UP FORM
    1. No Instruction available.
Header
Are data amended (check box if yes, and circle amended items)
Vital Status
Patient's Vital Status
Source of Survival Information (if alive)
Primary cause of Death (if dead)
Was there evidence of recurrence at the time of death?
Cancer Follow-up Status
Has the patient had a documented clinical assessment for this cancer (since submission of the last follow-up form)?
First Local-regional Recurrence
Has the patient been diagnosed with first local-regional recurrence (since submission of the last follow-up form)?
Site(s) of First Local-Regional Recurrence (mark all ipsilateral sites that apply)
First Distant Recurrence
Has the patient been diagnosed with first distant recurrence/progression (since submission of the last follow-up form)?
New Primary Cancer Or Mds
Has a new primary cancer or MDS been diagnosed that has not been previously reported?
Patient data
Has the patient had a menstrual period or vaginal bleeding in the last 12 months?
Has the patient had a hysterectomy?
Has the patient had a bilateral oophorectomy?
Was patient randomized to receive Celecoxib or Placebo?
Did the patient experience any of the following adverse events that have not been previously reported?
Adverse Events
Adverse Event
Grade
Late Adverse Events
Has the patient experienced any severe (Grade >= 3) adverse event, possibly related to the chemotherapy, that has not been previously reported?
Therapy
Did the patient receive any Herceptin treatment (since randomization since last follow-up)
Did the patient receive any systemic hormonal treatment (since randomization since last follow-up)
Tamoxifen
Anastrozole
Exemestane
Letrozole
LHRH agonist
Other, specify

Similar models

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial